Dominique Delbeke, M.D., Ph.D.

Faculty Appointments
Professor of Radiology and Radiological Sciences
Ph.D., Université Libre de Bruxelles , Brussels, BelgiumM.D., Université Libre de Bruxelles , Brussels, Belgium
Clinical Description
I am a nuclear medicine physician, Professor of Radiology and Radiological Sciences with Tenure and Director of Nuclear Medicine and Positron Emission Tomography at Vanderbilt University Medical Center. I am certified by the American Board of Nuclear Medicine and the American Board of Pathology. I am past-President of the Society of Nuclear Medicine and lifetime member of the American Board of Nuclear Medicine. I am the Editor-in-Chief of the Journal of Nuclear Medicine and serve on the Editorial Board of several imaging journals. I have co-edited five textbooks and published over 160 peer-reviewed articles including societal guidelines and 70 book chapters. I have given lectures at more than 100 national and 35 international meetings. I participate in both the Radiology and Nuclear Medicine Residency training program. Since 1990 when I became a faculty in Nuclear Medicine, there have been 57 Nuclear Medicine residents in the program. My primary expertise and research interest revolves around PET/CT and SPECT/CT primarily in oncology, but also in cardiology and neurology.
Research Keywords
Clinical Research Keywords
Nuclear Medicine/PET: oncology, neurology, cardiology
Deppen SA, Blume J, Bobbey AJ, Shah C, Graham MM, Lee P, Delbeke D, Walker RC. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J. Nucl. Med [print-electronic]. 2016 Jun; 57(6): 872-8. PMID: 26769864, PII: jnumed.115.165803, DOI: 10.2967/jnumed.115.165803, ISSN: 1535-5667.

Deppen SA, Liu E, Blume JD, Clanton J, Shi C, Jones-Jackson LB, Lakhani V, Baum RP, Berlin J, Smith GT, Graham M, Sandler MP, Delbeke D, Walker RC. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. J. Nucl. Med [print-electronic]. 2016 May; 57(5): 708-14. PMID: 26769865, PII: jnumed.115.163865, DOI: 10.2967/jnumed.115.163865, ISSN: 1535-5667.

Ayres KL, Spottswood SE, Delbeke D, Price R, Hodges PK, Wang L, Martin WH. Dose Optimization of the Administered Activity in Pediatric Bone Scintigraphy: Validation of the North American Consensus Guidelines. J. Nucl. Med [print-electronic]. 2015 Sep; 56(9): 1391-4. PMID: 26205299, PII: jnumed.115.156141, DOI: 10.2967/jnumed.115.156141, ISSN: 1535-5667.

Delbeke D. The Era of Evidence-Based Medicine: What Are the Implications for JNM and Other Imaging Journals? [editorial]. J. Nucl. Med. 2015 May; 56(5): 28A. PMID: 25934683, PII: 56/5/28A, ISSN: 1535-5667.

Delbeke D. Invited commentary. Radiographics. 2015 Mar; 35(2): 518-9. PMID: 25763735, DOI: 10.1148/rg.352140285, ISSN: 1527-1323.

Spottswood SE, Pfluger T, Bartold SP, Brandon D, Burchell N, Delbeke D, Fink-Bennett DM, Hodges PK, Jolles PR, Lassmann M, Maurer AH, Seabold JE, Stabin MG, Treves ST, Vlajkovic M, , . SNMMI and EANM practice guideline for meckel diverticulum scintigraphy 2.0. J Nucl Med Technol [print-electronic]. 2014 Sep; 42(3): 163-9. PMID: 24948825, PII: jnmt.113.136242, DOI: 10.2967/jnmt.113.136242.

Delbeke D, Chiti A, Christian P, Darcourt J, Donohoe K, Flotats A, Krause BJ, Royal HD. SNMMI/EANM guideline for guideline development 6.0. J Nucl Med Technol [print-electronic]. 2012 Dec; 40(4): 283-9. PMID: 22743147, PII: jnmt.112.108787, DOI: 10.2967/jnmt.112.108787.

Delbeke D, Royal HD, Frey KA, Graham MM, Segall GM. SNMMI/ABNM joint position statement on optimizing training in nuclear medicine in the era of hybrid imaging. J. Nucl. Med [print-electronic]. 2012 Sep; 53(9): 1490-4. PMID: 22836344, PII: jnumed.112.110346, DOI: 10.2967/jnumed.112.110346, ISSN: 1535-5667.

Li X, Abramson RG, Arlinghaus LR, Chakravarthy AB, Abramson V, Mayer I, Farley J, Delbeke D, Yankeelov TE. An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results. EJNMMI Res. 2012; 2(1): 62. PMID: 23157877, PMCID: PMC3520720, PII: 2191-219X-2-62, DOI: 10.1186/2191-219X-2-62, ISSN: 2191-219X.

Delbeke D, Segall GM. Status of and trends in nuclear medicine in the United States. J. Nucl. Med. 2011 Dec; 52 Suppl 2: 24S-8S. PMID: 22144551, PII: 52/Supplement_2/24S, DOI: 10.2967/jnumed.110.085688, ISSN: 1535-5667.

Delbeke D, Martin WH. FDG PET and PET/CT for colorectal cancer. Methods Mol. Biol. 2011; 727: 77-103. PMID: 21331930, DOI: 10.1007/978-1-61779-062-1_6, ISSN: 1940-6029.

Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Clin Nucl Med. 2010 Apr; 35(4): 237-43. PMID: 20305410, PII: 00003072-201004000-00004, DOI: 10.1097/RLU.0b013e3181d18eb0, ISSN: 1536-0229.

Delbeke D, Martin WH. PET and PET/CT for pancreatic malignancies. Surg. Oncol. Clin. N. Am. 2010 Apr; 19(2): 235-54. PMID: 20159513, PII: S1055-3207(09)00120-3, DOI: 10.1016/j.soc.2009.11.005, ISSN: 1558-5042.

Delbeke D, Schöder H, Martin WH, Wahl RL. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med. 2009 Sep; 39(5): 308-40. PMID: 19646557, PII: S0001-2998(09)00015-4, DOI: 10.1053/j.semnuclmed.2009.03.002, ISSN: 1558-4623.

Dong C, Sriram S, Delbeke D, Al-Kaylani M, Arain AM, Singh P, McLean MJ, Abou-Khalil B. Aphasic or amnesic status epilepticus detected on PET but not EEG. Epilepsia [print-electronic]. 2009 Feb; 50(2): 251-5. PMID: 18801038, PII: EPI1782, DOI: 10.1111/j.1528-1167.2008.01782.x, ISSN: 1528-1167.

Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist. 2009; 14 Suppl 2: 30-40. PMID: 19819922, PII: 14/suppl_2/30, DOI: 10.1634/theoncologist.2009-S2-30, ISSN: 1549-490X.

Walker RC, Jones-Jackson LB, Martin W, Habibian MR, Delbeke D. New imaging tools for the diagnosis of infection. Future Microbiol. 2007 Oct; 2(5): 527-54. PMID: 17927475, DOI: 10.2217/17460913.2.5.527, ISSN: 1746-0921.

Malkerneker D, Brenner R, Martin WH, Sampson UK, Feurer ID, Kronenberg MW, Delbeke D. CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress Tc-99m tetrofosmin SPECT MPI. J Nucl Cardiol [print-electronic]. 2007 May; 14(3): 314-23. PMID: 17556165, PII: S1071-3581(07)00116-X, DOI: 10.1016/j.nuclcard.2007.02.005, ISSN: 1532-6551.

Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Zubal G, Cronin V, . Procedure Guideline for SPECT/CT Imaging 1.0. J. Nucl. Med. 2006 Jul; 47(7): 1227-34. PMID: 16818960, PII: 47/7/1227.

Rhodes MM, Delbeke D, Whitlock JA, Martin W, Kuttesch JF, Frangoul HA, Shankar S. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J. Pediatr. Hematol. Oncol. 2006 May; 28(5): 300-6. PMID: 16772881, PII: 00043426-200605000-00006, DOI: 10.1097/01.mph.0000212912.37512.b1, ISSN: 1077-4114.

Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MG, Zubal G, Kachelriess M, Cronin V, Holbrook S. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J. Nucl. Med. 2006 May; 47(5): 885-95. PMID: 16644760, PII: 47/5/885.

Roman CD, Martin WH, Delbeke D. Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med. 2005 Jul; 30(7): 470-7. PMID: 15965321, PII: 00003072-200507000-00002, ISSN: 0363-9762.

Delbeke D, Martin WH. Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HPB (Oxford). 2005; 7(3): 166-79. PMID: 18333185, PMCID: PMC2023947, DOI: 10.1080/13651820510028909, ISSN: 1365-182X.

Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging [print-electronic]. 2004 Oct; 31(10): 1435-42. PMID: 15221294, DOI: 10.1007/s00259-004-1565-2, ISSN: 1619-7070.

Delbeke D, Martin WH. Metabolic imaging with FDG: a primer. Cancer J. 2004 Jul; 10(4): 201-13. PMID: 15383201, ISSN: 1528-9117.

Delbeke D, Pinson CW. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg. 2004; 11(1): 4-10. PMID: 15747028, DOI: 10.1007/s00534-002-0775-x, ISSN: 0944-1166.

Delbeke D, Martin WH, Patton JA, Sandler MP. Value of Iterative reconstruction, attenuation correction, and image fusion for interpretation of FDG images using an intergrated dual-head coincidence camera with X-ray based attenuation maps in patients with known or suspected malignancy. Radiology. 2001; 218: 163-71.

Delbeke D, Kovalsky E, Morgan DS, Martin WH, Kinney M, Arrowsmith T, Greer J. 18F-fluorodeoxyglucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma. Molecular Imaging and Biology. 2001; 4: 105-14.

Delbeke, D, Sandler, MP. The role of hybrid cameras in oncology. Semin Nucl Med. 2000; 20((4)): 268-80.

Delbeke D, Patton JA, Martin WH, Sandler MP. FDG PET and dual-head gamma camera positron coincidence detection imaging using a dual head gamma camera of suspected malignancies and brain disorders. J Nucl Med. 1999; 40((1999)): 110-7.

Boren EB, Delbeke D, Patton JA, Sandler MP. Comparison of FDG PET and Positron Coincidence Dectection Imaging Using a Dual Head Gamma Camera (DHC) with 5/8 inch Nal(TI) Crystals in patients with Suspected Body Malignancies. Europ J Nucl Med. 1999; 26: 379-87.

Delbeke D. Oncological applications of FDG-PET imaging: Brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med. 1999; 40: 591-603.

Delbeke D. Oncological applications of FDG-PET imaging: Breast cancer, pancreatic cancer, hepatocellular carcinomas and other body tumors. J Nucl Med. 1999; 40: 1706-16.

Delbeke D, Rose M, Chapman WC, Pinson CW, Wright JK, Beauchamp DR, Leach S. Optimal interpretaion of F-18FDG Imaging with positron emission tomography significantly impacts the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med. 1999; 40: 1784-92.

Editors: Delbeke D, Martin WH, Patton JA, Sandler MP Publisher:Springer-Verlag, NY, NY, 2002. Practical FDG Imaging: A teaching File.